Editorial Compass News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elizabeth cohen. She joins us with the breaking details. What do you have, elizabeth . Alisyn, so the bottom line here is that we may soon have a third vaccine in the United States. We already have pfizer, moderna and with these results, its almost certain Johnson Johnson will be applying for Emergency Use Authorization from the fda. The bottom line, this vaccine does not seem to be as effective as pfizer or moderna but has impressive results and is still useful. Lets go over these specific numbers. The Johnson Johnson trial data shows that when you are looking at moderate to severe cases of covid19, it was 66 effective at putting preventing those, whereas moderna and pfizer was 95 . Those two were 95 . Thats a significant difference. If you look at preventing severe cases of covid19, which is the more important one, right . We dont want people in the hospital. We dont want people in the icu or dying. Johnson johnson was 85 effective at preventing severe cases. Moderna and pfizer were

Breaking newsPhase three trialBattle against coronavirusElizabeth cohenU sAlisyn camerotaEmergency use authorizationBottom lineLet s goCovid 19South africaLab resultsSouth african variantAnother vaccinemakerJohn harwoodVaccine advisory committee